Internal Medicine News - Ramipril cuts diabetes risk
Saturday, January 3rd, 2009 The ACE inhibitor ramipril appears to reduce the risk of developing diabetes among high-risk patients who take it to prevent myocardial infarction, stroke, and diabetic nephropathy, reported Salim Yusuf, D.Phil., and associates in the Heart Outcomes Prevention Evaluation trial.
The HOPE trial involved more than 10,000 subjects treated at 267 hospitals around the world between 1994 and 1999. A subgroup of 5,887 patients who were at risk for diabetes but did n…
